Back to Search
Start Over
supplementary tables from Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary table 1 Primers sequences used for Real-Time qPCR. Supplementary table 2 ShRNA used for inhibition of the receptors, for each receptor the most effective shRNA was selected as tested with Real-Time qPCR. Supplementary table 3 Sequence of the primers used for ChIP-qPCR.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....14386f00029181604781520ebdd88e28